Intel has accelerated the production timeline for its next generation 1.4 nanometer manufacturing process. The company is moving risk production for internal products to the second half of 2027, aiming for high volume manufacturing in 2028. But the chipmaker still faces the steep challenge of proving its yields can compete with established rivals like TSMC.
The updated timeline comes directly During a strong Q2 earnings report. Intel reported $16.1 billion in revenue, marking one of its largest quarterly growth periods. This financial strength gives Intel Foundry the backing it needs to expand capital expenditure to over $20 billion this year. This money is going directly into foundry upgrades and facility updates.
Managing defect density is the biggest hurdle for any advanced node. Currently, Intel’s 14A defect rate sits at 0.5. At this rate, a Panther Lake compute tile would achieve a yield of 56.45% for a die size of 114.304 square millimeters. Intel wants to drop that defect rate to 0.1 before mass production starts. Doing so would boost yields into the 80% to 90% range, ensuring commercial viability.
CEO Lip Bu Tan confirmed that the 14A process design kit has reached version 0.5. Version 0.9 is scheduled to ship to customers in October. This kit gives design teams the tools to build chips for the node. Intel expects 14A to outshine 18A on performance, power efficiency, and transistor density. Early tests will begin in late 2027, paving the way for the 2028 volume ramp.
Other manufacturing processes are also hitting their marks. Intel 7, Intel 3, and Intel 18A all beat their volume targets, and risk production of 18A P is already underway. But the competition is not standing still. AMD is rumored to be planning its Zen 7 processors around TSMC's A14 process, while Apple is actively exploring its options. Reaching high yields will decide whether Intel can steal these big fish from its rivals.
